Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct ...

In 2023 Dr. Vinay Prasad said that scientists who recognized the limitations of randomized-controlled trials (RCTS) were ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

The Trump Administration is considering limiting approval for COVID-19 boosters to seniors and others at high risk pending more data — leaving some New Yorkers who want a vaccine wondering if they ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

In those terms, Prasad meant a major departure from the FDA strategy for authorizing COVID-19 vaccines that ... new head of vaccines at the FDA, Dr. Vinay Prasad, stressed more evidence is needed ...

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition ...